Skip to main content

Metipranolol ophthalmic Side Effects

Medically reviewed by Drugs.com. Last updated on Sep 25, 2023.

Applies to metipranolol ophthalmic: ophthalmic solution.

Serious side effects

Along with its needed effects, metipranolol ophthalmic may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking metipranolol ophthalmic:

Incidence not determined

Get emergency help immediately if any of the following symptoms of overdose occur while taking metipranolol ophthalmic:

Symptoms of overdose

Other side effects

Some side effects of metipranolol ophthalmic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Incidence not determined

For Healthcare Professionals

Applies to metipranolol ophthalmic: ophthalmic solution.

General

The most commonly reported side effects were abnormal vision, blurred vision, conjunctivitis, and tearing.[Ref]

Ocular

Frequency not reported: Abnormal vision, blepharitis, blurred vision, browache, conjunctivitis, edema, eyelid dermatitis, photophobia, tearing, uveitis, eye discomfort[Ref]

Cardiovascular

Frequency not reported: Angina, atrial fibrillation, bradycardia, hypertension, palpitation, myocardial infarct[Ref]

Respiratory

Frequency not reported: Bronchitis, coughing, dyspnea, epistaxis, rhinitis[Ref]

Nervous system

Frequency not reported: Dizziness, headache, nervousness, somnolence[Ref]

Hypersensitivity

Frequency not reported: Allergic reaction[Ref]

Psychiatric

Frequency not reported: Anxiety, depression[Ref]

Musculoskeletal

Frequency not reported: Arthritis, myalgia[Ref]

Other

Frequency not reported: Asthenia[Ref]

Gastrointestinal

Frequency not reported: Nausea[Ref]

Dermatologic

Frequency not reported: Rash[Ref]

References

1. (2022) "Product Information. OptiPranolol (metipranolol ophthalmic)." Bausch and Lomb Americas, Inc.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.